Immediate Impact
1 from Science/Nature 53 standout
Citing Papers
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
2024 Standout
Works of So Nagai being referenced
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study ( SWITCH‐SEMA 1 study)
2023
Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study ( SWITCH‐SEMA 2 study)
2023
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| So Nagai | 226 | 270 | 105 | 195 | 50 | 674 | |
| Katsuhiro Miyajima | 230 | 260 | 133 | 185 | 69 | 781 | |
| Shinichiro Koike | 146 | 210 | 96 | 305 | 20 | 663 | |
| S Kralisch | 154 | 291 | 229 | 248 | 28 | 744 | |
| Hilda Vargas‐Robles | 109 | 275 | 113 | 121 | 42 | 792 | |
| Ming Lu | 192 | 349 | 127 | 163 | 36 | 813 | |
| R. Renner | 272 | 242 | 34 | 157 | 41 | 718 | |
| Tetsu Ebara | 353 | 229 | 81 | 111 | 28 | 792 | |
| Takatoshi Saito | 121 | 437 | 51 | 170 | 28 | 817 | |
| Jean‐Pierre Clot | 222 | 275 | 46 | 203 | 35 | 766 | |
| Munetada Oimomi | 307 | 176 | 69 | 184 | 60 | 811 |
All Works
Loading papers...